Notificaciones De Seguridad De Campo acerca de Medtronic MiniMed Infusion Sets

Según Ministry of Health, State Institute for Drug Control, Coordination Center for Departmental Medical Information Systems, este evento ( notificaciones de seguridad de campo ) involucró a un dispositivo médico en Czechia que fue producido por Unomedical a/s.

¿Qué es esto?

Las notificaciones de seguridad de campo son comunicaciones sobre acciones que se pueden estar tomando en relación con un producto que se encuentra en el mercado, enviadas por los fabricantes de dispositivos médicos o sus representantes. Estas notificaciones son principalmente para trabajadores de la salud, pero también para usuarios. Pueden incluir alertas y retiro de equipos.

Más información acerca de la data acá
  • Tipo de evento
    Field Safety Notice
  • ID del evento
    1332
  • Fecha
    2017-11-30
  • País del evento
  • Fuente del evento
    MHSIDCCCDMIS
  • URL de la fuente del evento
  • Notas / Alertas
    Czech data is current through July 2018. All of the data comes from the Czech Public Registry of Medical Devices, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and the Czech Republic.
  • Notas adicionales en la data

Device

  • Modelo / Serial
    Model Number: Medtronic MiniMed Quick-set (MMT-394, 384, 399, 387, 398, 397, 386, 396) Medtronic MiniMed Silhouette (MMT-377, 378, 384, 368, 381, 382, 383) Medtronic MiniMed Sure-T (MMT-862, 862T, 864, 866, 874, 876, 884, 886) Medtronic MiniMed Mio (MMT-921, 923, 925, 941, 943, 945, 961, 963, 965, 975) Medtronic MiniMed Mio 30 (MMT-905, 906)
  • Descripción del producto
    Medical devices for single use
  • Manufacturer

Manufacturer

  • Empresa matriz del fabricante (2017)
  • Comentario del fabricante
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    MHSIDCCCDMIS